Izotropic Corporation belongs to the Health Care sector. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for Izotropic Corporation. The previous disclosure was published on 17 September 2025.
Our records for Izotropic Corporation go back to 2018, with 6 purchases and no sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended April 2026 · cache
23 of 23 declarations
Izotropic Corporation is a company listed on the XTSE, specializing in the development of innovative medical technologies. It focuses on solutions for the diagnosis and treatment of bone health-related diseases.